| Terry A Housinger, MD | |
|
801 N 29th St, Billings, MT 59101-0905 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | Terry A Housinger |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 801 N 29th St, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790705234 | NPI | - | NPPES |
| 101498600 | Other | WY | MDCD PIN |
| 000003631 | Other | MT | BCBS PIN |
| 0011339 | Other | MT | MDCD PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 7083 (Montana) | Primary |
| 2086S0102X | Surgery - Surgical Critical Care | 7083 (Montana) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Terry A Housinger, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Terry A Housinger, MD 801 N 29th St, Billings, MT 59101-0905 Ph: (406) 238-2500 |
News Archive
Endocyte, Inc., a biopharmaceutical company developing targeted small-molecule drug conjugates, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.
Constantly evolving value chains, market innovations, and cutting-edge technology developments are pushing 3D printing into the mainstream market.
More consumers than ever before are seeking additional knowledge to make more informed decisions, especially when it comes to their health care.
A single hour of general anesthesia in early infancy—longer than is necessary to perform the most common types of minor surgeries in childhood—does not result in measurable neurodevelopmental or behavioral problems up to the age of 5 years, according to the first randomized trial of its kind involving 722 infants in seven countries, published in The Lancet.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 1 days ago
Thomas Mitchell Gallagher, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2510 17th St W, Billings, MT 59102 Phone: 406-245-3238 Fax: 406-248-6814 | |
Fred V Schneider, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2900 12th Ave N, Ste 502e, Billings, MT 59101 Phone: 406-245-6982 Fax: 406-245-1539 | |
Robert J Hancock, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Nolan Mann, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Scott H. Dull, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Jeffrey R Balison, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2345 King Ave W, Billings, MT 59102 Phone: 406-651-5670 | |
Bret Murray, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 |